September 26, 2016: Mark Zuckerberg, CEO of Facebook, and his wife, Priscilla Chan, a physician, last year created the Chan Zuckerberg Initiative, which pledged $3B toward basic science research over the next 10 years.
September 26, 2016: It’s time to think about which stocks might give you the best return on investment and analysts at 24/7 Wall Street picked six biotech companies that could include a 50 percent to 150 percent upside.
September 26, 2016: Pfizer has been considering splitting into two companies since at least 2012. This was clearly at the forefront during its attempts to merge with Allergan. The company announced today, however, that after lengthy evaluation, it has decided not to split the company.
September 26, 2016: In the biotech world, super cheap stocks, those under $5 per share, represent very high risk. But George Budwell, writing for The Motley Fool, points out two that might be worthwhile for investors who are risk-tolerant, while identifying one to avoid.